| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.5M | +66.0% |
| R&D Expense | $79.9M | +8.7% |
| SG&A Expense | $56.8M | +52.5% |
| Operating Income | -$112.8M | -16.4% |
| Interest Expense | $10.7M | +313.3% |
| Pre-tax Income | -$16.4M | +83.4% |
| Income Tax | $3.4M | — |
| Net Income | -$19.8M | +79.9% |
| EPS (Basic) | -$0.51 | +81.0% |
| EPS (Diluted) | -$0.51 | +81.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $240.6M | +95.7% |
| Accounts Receivable | $6.3M | +141.5% |
| Inventory | $77K | — |
| Current Assets | $252.4M | +91.7% |
| Total Assets | $259.5M | +89.7% |
| Current Liabilities | $25.0M | -38.3% |
| Long-term Debt | $75.0M | +66.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$112.9M | -103.5% |
| Investing Cash Flow | $105.8M | +7575.1% |
| Financing Cash Flow | $124.7M | +202.0% |
| Total Liabilities |
| $143.5M |
| +72.2% |
| Stockholders' Equity | $116.0M | +116.9% |